Nu Skin Enterprises Inc. announced plans for a joint research and development relationship with Toyo Bio-Pharma Inc. (a subsidiary of Toyo Shinyaku, Japan), a natural products manufacturer with locations in the United States and Japan. To facilitate this relationship, the companies have reportedly established a new joint venture—NU Toyo Research Inc., in the United States.
The companies' collaborative development efforts will focus on sharing scientific and regulatory insights, as well as developing proprietary nutraceutical and cosmeceutical products for Nu Skin sales through its worldwide distribution network.
“We expect this relationship with Nu Skin Enterprises to nicely complement our current expertise in natural health supplements,” said Yoshi Shiraishi, president and chief operating officer of Toyo Bio- Pharma, in a press announcement.
“Toyo Bio-Pharma is a subsidiary of Toyo Shinyaku, which is one of the most reputable supplement and skin care manufacturers in Japan, and we look forward to developing a robust relationship with joint development opportunities,” said Joseph Chang, PhD, chief scientific officer and executive vice president of product development at Nu Skin Enterprises, in the press release. “We are eager to leverage their knowledge of navigating regulatory requirements for skin care and supplements in Japan.”
Toyo Shinyaku (www.toyobiopharma.com) uses fermentation and culturing to produce products for use in the nutraceutical, functional food and cosmeceutical industries. Toyo Shinyaku is Japan's largest developer of Food for Specialized Health Use (FOSHU) products and Original Design Manufacturer (ODM) of supplement and skin care products.
